Nhân một trường hợp đái đường do đột biến gen Kir6.2 điều trị thành công với Glibenclamide có thay thế cho Insulin

Chỉ số đề mục

76.29.37

Lĩnh vực nghiên cứu

Y học lâm sàng

Dạng tài liệu

Tác giả

Cấn Thị Bích Ngọc⁽²⁾, Vũ Chí Dũng⁽¹⁾, Nguyễn Thị Hoàn

Nhan đề

Nhân một trường hợp đái đường do đột biến gen Kir6.2 điều trị thành công với Glibenclamide có thay thế cho Insulin

Nhan đề tiếng anh

Switching from insulin to oral sulfonylureas in patients with neonatal diabetes mellitus due to Kir6.2 gene mutations: a case report

Nguồn trích

Y học Việt Nam

Năm xuất bản

2012

Số

DB

Trang

405-410

ISSN

1859-1868

Từ khóa

Tiểu đường, Đột biến gen Kir6.2, Glibenclamide, Điều trị, Thay thế Insulin

Từ khóa tiếng anh

Tóm tắt

Tóm tắt tiếng anh

Neonatal diabetes mellitus is a rare disorder that is difine as insulin requiring hyperglycemia within the first months of life. Heterozygous activating mutations in the KCNJ11 and ABCC8 genes, which encode the KATP channel subunits Kir6.2 have recently been identified. Object: determine gen mutation in neonatal diabetes mellitus patients and ascess the result of transfer from insulin infections to Glibenclamide. Subject: the patients was diagnosed diabetes mellitus with Kir6.2 mutation within the 6 first months of life. Method: case study. Result: a 5.5 year - old girl was diagnosed diabetes mellitus when she was 45 days of age. Now she has been treating with insulin mixtard 70/30 subtaneous injection with dose of 14 units at morning and 10 units at evening. She was indentified Kir6.2 mutation by sequencing in United Kingdom. She was tranfered from insulin injection to Glibenclamide. After 2 week, transfer to Glibenclamide therapy has been successful. She has to treat only with oral Glibenclamide. The level of blood glucose is very good. Conclusion: Transfer to sulphonylurea therapy has been successful for patients with Kir6.2 mutation and results in improved glycaemic control.

Kí hiệu kho

TTKHCNQG, CVv46

File toàn văn

Xem toàn văn